GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000105) » Definitions » Gross-Profit-to-Asset %

Yuhan (XKRX:000105) Gross-Profit-to-Asset % : 19.16% (As of Mar. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Yuhan's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₩538,032 Mil. Yuhan's average Total Assets over the quarter that ended in Mar. 2024 was ₩2,807,662 Mil. Therefore, Yuhan's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 19.16%.


Yuhan Gross-Profit-to-Asset % Historical Data

The historical data trend for Yuhan's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Gross-Profit-to-Asset % Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.08 24.76 21.60 20.99 21.41

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.85 24.47 22.34 19.41 19.16

Competitive Comparison of Yuhan's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yuhan's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Yuhan's Gross-Profit-to-Asset % falls into.



Yuhan Gross-Profit-to-Asset % Calculation

Yuhan's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=565863.818/( (2472728.072+2814070.522)/ 2 )
=565863.818/2643399.297
=21.41 %

Yuhan's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=538031.736/( (2814070.522+2801252.649)/ 2 )
=538031.736/2807661.5855
=19.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Yuhan Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Yuhan's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuhan (XKRX:000105) Business Description

Traded in Other Exchanges
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000105) Headlines

No Headlines